Hospira Vincristine Injection, 2 mg/2 mL vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

vincristine sulfate, Quantity: 1 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Vincristine sulfate

formulario farmacéutico:

Injection

Composición:

Excipient Ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide

Vía de administración:

Intravenous

Unidades en paquete:

5 x 2 mL vial

clase:

Medicine Listed (Export Only)

tipo de receta:

Not scheduled. Not considered by committee

indicaciones terapéuticas:

Vincristine sulphate is used either alone or in conjunction with other oncolytic drugs for the treatment of: leukaemias, malignant lymphomas, multiple myeloma, breast carcinoma, small cell bronchogenic carcinoma, head and neck carcinoma, soft tissue sacomas, paediatric solid tumours and idiopathic thrombocytopenic purpura.

Resumen del producto:

Visual Identification: A clear, colourless solution; Container Type: Vial; Container Life Time: 18 Months

Estat d'Autorització:

Licence status A

Data d'autorització:

2007-07-31